)

The Chemours Company (CC) investor relations material
The Chemours Company Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Net sales reached $1.6B in Q2 2025, up 4% year-over-year, driven by strong Opteon™ demand and favorable pricing in APM, but offset by lower TT pricing and operational disruptions.
Adjusted EBITDA was $253M, up 22% year-over-year, with margin pressure in TT and higher litigation charges; net loss was $381M due to a $257M PFAS settlement charge.
Achieved a comprehensive $250M–$257M settlement with New Jersey to resolve all environmental and PFAS claims, with insurance and escrow funds covering payments through at least 2030.
Returned $13M to shareholders via dividends and continued execution of the Pathway to Thrive strategy, including cost reductions and portfolio optimization.
Financial highlights
Q2 2025 net sales were $1,615M, up from $1,554M year-over-year and $1,368M sequentially; adjusted EBITDA rose to $253M from $207M year-over-year.
Net loss was $(381)M, or $(2.54) per share, primarily due to litigation settlements; adjusted net income was $87M, or $0.58 per share.
Free cash flow improved to $50M from $(693)M year-over-year; operating cash flow for the quarter was $93M.
Capex for Q2 was $43M, down from $73M year-over-year; full-year 2025 CapEx expected at $250M.
Gross margin for Q2 2025 was 17.2%, down from 19.8% in Q2 2024.
Outlook and guidance
Q3 2025 net sales expected to decrease 4–6% sequentially; adjusted EBITDA forecasted at $175M–$195M.
Full-year 2025 net sales projected at $5.9B–$6.0B, adjusted EBITDA at $775M–$825M, and free cash flow conversion for H2 at 60–80%.
Capital expenditures for 2025 anticipated at $250M; net leverage ratio expected to improve through 2025.
TSS and TT segments expect sequential sales and EBITDA declines in Q3 due to seasonality and operational disruptions; APM faces production constraints from a site outage.
Management expects continued positive cash flow from operations in 2025 and compliance with debt covenants through at least August 2026.
Next The Chemours Company earnings date

Next The Chemours Company earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage